Price change (24h):
1.68%
High (24h):
$1167.76
Low (24h):
$1137.31
Volume (24h):
$1.05M
Market Cap:
$4.96M
All Time High:
7.04% $1226.36
Jun 8, 2026
All Time Low:
60% $713.06
Sep 25, 2025
0.00 %(1Y)
$1140.01
Price change (24h):
1.68%
High (24h):
$1167.76
Low (24h):
$1137.31
Volume (24h):
$1.05M
Market Cap:
$4.96M
All Time High:
7.04% $1226.36
Jun 8, 2026
All Time Low:
60% $713.06
Sep 25, 2025
Eli Lilly Tokenized Stock (Ondo) is a cryptocurrency that replicates the economic performance of Eli Lilly and Company equity, automatically channeling any declared dividends back into the token’s net asset value. It sits squarely inside the tokenized stock niche, a subset of real-world assets that bridges regulated equity markets and decentralized finance rails.
The token operates within Ondo Finance’s global markets protocol, a structure engineered to erase the geographic and temporal moats that wall off U.S. equities from non-U.S. capital. Non-U.S. retail traders and institutional desks can mint or redeem LLYon against custodially held shares during a continuous 24-hour, five-day window, sidestepping the T+2 settlement drag and intermediary stack of legacy exchanges. Fractional precision is native to the contract, so an investor can hold a sliver of a share without confronting the lot-size constraints of traditional venues.
LLYon lives on the Ethereum blockchain as an ERC-20 asset, with bridged deployments on BNB Smart Chain and Solana. These mirrored instances all reference the same underlying share pool but scatter liquidity across distinct ecosystems, multiplying the points where price discovery and arbitrage can occur. Ethereum’s sprawling lending protocols, BNB Chain’s high-throughput decentralized exchanges, and Solana’s sub-second finality each bend the token to their own composability logic.
The Ethereum contract conforms to the ERC-20 standard, while its Solana and BNB Chain counterparts use SPL and BEP-20 standards respectively, guaranteeing broad compatibility with wallets and smart contracts. A regulated custodian safeguards the reference LLY shares, and only upon deposit of the corresponding equity or fiat does the protocol emit new tokens; burning extinguishes the on-chain claim, keeping supply magnetically locked to the backing stock. This mint-and-burn architecture acts as a real-time attestation of full collateralization, making dilution purely a function of equity purchases.
Ondo Finance, the token’s issuer, constructed the Ondo Global Markets framework to port conventional securities onto public ledgers without shortchanging custody standards or regulatory clarity. LLYon rolled out as a natural extension of the platform’s existing tokenized U.S. Treasury funds, applying the same full-reserve vault model to a blue-chip pharmaceutical stock. Its launch layered equity exposure into the same compliance-first rails that had already pooled significant liquidity around Ondo’s yield-bearing products.
The deeper objective driving LLYon is the wholesale rewiring of cross-border securities infrastructure: a stock that can flow through automated market makers, lending pools, and structured products without ever touching a traditional broker. Porting Eli Lilly onto blockchains turns a static, exchange-locked equity into a composable primitive, one that can settle in seconds rather than days and shed the cumulative fee drag of custodians, clearing houses, and transfer agents.
Functionally, LLYon represents a transferable receipt of beneficial interest in a custodian-segregated pool of LLY shares. Dividends issued by Eli Lilly are automatically swept into that pool and reinvested, quietly compounding the underlying asset base behind each token. The contract confers no shareholder voting power; its entire mechanical purpose distills to granting bearer-style economic exposure and frictionless transferability across any chain where the token is recognized.
A Singapore-based fund can accumulate LLYon during weekend hours to front-run FDA news, reacting long before the Nasdaq opening bell. Decentralized lending markets accept the token as collateral, enabling leverage on equity without liquidating the stock in the old system. Arbitrageurs exploit on-chain premiums by minting tokens and off-chain discounts by redeeming them, compressing spreads and pulling the token’s price in line with its reference equity.
Eli Lilly Tokenized Stock (Ondo) has a total supply of 4,193.66 tokens. Currently, 4,193.66 are in circulation. With a market capitalization of $3,711,615.00, Eli Lilly Tokenized Stock (Ondo) ranks #1,852 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 12/06/2026 | $1,163.84 | $1,143.15 | $1,167.76 | $1,142.95 |
| 11/06/2026 | $1,142.57 | $1,166.93 | $1,169.13 | $1,133.64 |
| 10/06/2026 | $1,149.95 | $1,142.47 | $1,165.91 | $1,142.01 |
| 09/06/2026 | $1,152.85 | $1,147.22 | $1,171.45 | $1,147.04 |
| 08/06/2026 | $1,132.79 | $1,154.59 | $1,226.36 | $1,128.83 |
| 07/06/2026 | $1,132.58 | $1,131.11 | $1,133.14 | $1,128.09 |
| 06/06/2026 | $1,135.96 | $1,129.27 | $1,138.15 | $1,125.29 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.